Barclays’s NEVRO CORP. NVRO Stock Holding History

Barclays’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,400	Closed	-$927K	–	5415
2022 Q4	$927K	Buy	+23,400	New	+$973K	﹤0.01%	2870
2021 Q1	–	Sell	-44,000	Closed	-$7.62M	–	5290
2020 Q4	$7.62M	Buy	+44,000	New	+$7.13M	﹤0.01%	1293
2019 Q1	–	Sell	-35,100	Closed	-$1.36M	–	7390
2018 Q4	$1.36M	Buy	+35,100	New	+$1.56M	﹤0.01%	2799
2018 Q3	–	Sell	-21,600	Closed	-$1.73M	–	7449
2018 Q2	$1.73M	Buy	21,600 +15,400	+248%	+$1.28M	﹤0.01%	2711
2018 Q1	$537K	Buy	+6,200	New	+$501K	﹤0.01%	3909
2017 Q2	–	Sell	-2,500	Closed	-$234K	–	6992
2017 Q1	$234K	Buy	+2,500	New	+$226K	﹤0.01%	4157
2016 Q4	–	Sell	-2,800	Closed	-$292K	–	6877
2016 Q3	$292K	Buy	+2,800	New	+$253K	﹤0.01%	3648

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays's NVRO Position: Q2 2025 in Review

Barclays sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 51,151 shares — an estimated $299K sold.

Barclays first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $10.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

Barclays reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
Barclays sold 51,151 NEVRO CORP. shares in Q2 2025, an estimated $299K.
Barclays first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
Barclays's NEVRO CORP. position peaked at $10.4M in Q4 2021.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.